Сообщение
mishka » Пт июл 14, 2017 7:55 pm
Второй патент
Agent with anticancer activity for treating cytotoxic effects of paraneoplastic processes and chemotherapy. Prosenko, A. E.; Gross, M. A.; Kandalintseva, N. V.; Tolstikova, T. G.; Sorokina, I. V. (Nekommercheskoe Partnerstvo "Novosibirskii Institut Antioksidantov", Russia). Russ. (2012), 19pp. CODEN:RUXXE7 RU 2447888 C1 20120420 Patent written in Russian. Application: RU 2011-114190 20110411. Priority: RU 2011-114190 20110411. CAN 156:525480 AN 2012:575030 CAPLUS
ABSTRACT
The invention refers to medicine, more specifically to (3,5-dimethyl-4-hydroxy)benzylthiododecane. Compd. shows anticancer, membrane-stabilizing, cytoprotective activity and may be used for reducing paraneoplastic and chemotherapy-assocd. toxicity.